From the Editor

Managing change in oncology


 

As I write this, the permanent fix to the sustainable growth rate (SGR) has been passed overwhelmingly in the US House of Representatives. The Senate has adjourned for spring break so has yet to vote on the fix, but there is optimism that it will pass when the session resumes. Doctors have feared that the 21% payment reduction that would automatically be triggered if the SGR fix were not passed would result in them having to close their doors to Medicare patients. Congress has postponed the SGR cuts 17 times since 2003. The uncertainty around this legislation and the time that practicing oncologists have spent conjuring up temporary solutions since 2003 is maddening.
Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Indocyanine green technique detects sentinel nodes in breast cancers
MDedge Hematology and Oncology
Nurses’ Health Study: No link between depression and breast cancer
MDedge Hematology and Oncology
Physician-patient communication, terminology play important role in CPM decisions
MDedge Hematology and Oncology
False-positive mammograms cost $2.8 billion a year
MDedge Hematology and Oncology
Type, location of BRCA mutations influence risk
MDedge Hematology and Oncology
Neoadjuvant therapy facilitates breast conservation
MDedge Hematology and Oncology
Sleep disorders in patients with cancer
MDedge Hematology and Oncology
Task Force: Start biennial mammograms at age 50
MDedge Hematology and Oncology
Class of 2015: New drugs projected to earn billions and billions
MDedge Hematology and Oncology
PD-L1 blockade breaks through triple-negative breast cancer
MDedge Hematology and Oncology